FTC Merger Guidelines Cast ‘Perilous Shadow’ Over Biopharma

 
• By Brenda Sandburg
  
Merger shadow
BIO and others recommend changes to FTC-DOJ proposed revision to merger guidelines. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Compliance

More from Pink Sheet